Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause that can occur at almost any age, although it affects mostly women in their 20s. The annual incidence of SLE is 50–70 people per million of the population, and prevalence is 500 per million [1]. The incidence of new cases and the survival of patients with SLE are both increasing [2]. The disease is characterized by a large variety of organ disorders involving many different immune mechanisms. The spectrum of kidney lesions predominantly involves the glomerulus and includes minimal mesangial alterations to florid proliferative lesions with necrosis and crescents but also extends to nonimmune complex lesions such as thrombotic microangiopathy (see Chap. 11) and direct podocyte injury. Correspondingly, clinical manifestations and course are equally diverse. Kidney disease develops in more than half of lupus patients and represents the first clinical manifestation of SLE in 15–20 % [3, 4]. Moreover, renal alterations are found in almost 90 % of lupus patients at autopsy. The lowest 5-year survival has been reported for patients with central nervous system and renal involvement [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Picken MM (1998) The role of kidney biopsy in the management of patients with systemic lupus erythematosus. Pathol Case Rev 3:204–209
Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV (2001) Systemic lupus erythematosus. Lancet 357:1027–1032
Appel GB, Radhakrishnan J, D'Agati V (2007) The kidney, 8th edn. Saunders, Philadelphia
Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10:413–424
Petri M (2005) Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 31:245–254
Weening JJ, d’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M, International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250
Donadio JV Jr, Glassock RJ (1993) Immunosuppressive drug therapy in lupus nephritis. Am J Kidney Dis 21:239–250
Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S (1993) Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice. Nephron 64:471–475
Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59:2156–2163
Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ, Lupus Nephritis Collaboration Study Group (1992) Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 42:743–748
Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ, Lupus Nephritis Collaboration Study Group (1993) Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Am J Kidney Dis 21:374–377
Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P (1993) Lupus membranous nephropathy: long-term outcome. Clin Nephrol 39:175–182
Mercadal L, Tezenas du Montcel S, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F (2002) Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 17:1771–1778
Jennette JC, Iskandar SS, Dalldorf FG (1983) Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24:377–385
Haas M, Zikos D (1998) Membranous nephropathy. Distinction of latent membranous lupus nephritis from idiopathic membranous nephropathy on renal biopsy. Pathol Case Rev 3:175–179
Gunnarsson I, Schlumberger W, Rönnelid J (2012) Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 59:585–586
Schwartz MM, Kawala K, Roberts JL, Humes C, Lewis EJ (1984) Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol 4:301–311
D’Agati V, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2:368–382
Bruijn JA, Cotran RS (1992) The aging kidney: pathologic alterations. In: Martinez-Maldonado M (ed) Hypertension and renal disease in the elderly. Blackwell Scientific, Boston, pp 1–10
Giannico G, Fogo AB (2013) Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol 8:138–145
Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D’Agati VD (2002) Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57:120–126
Kraft SW, Schwartz MM, Korbet SM, Lewis EJ (2005) Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16:175–179
Han TS, Schwartz MM, Lewis EJ (2006) Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 15:71–75
Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, Yip J, Nasr SH, Thomas D, Scholey JW, Wither J, Urowitz M, Gladman D, Reich H, Fortin PR (2012) Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol 7:757–774
Appel GB, Pirani CL, D’Agati V (1994) Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4:1499–1515
Banfi G, Bertani T, Boeri V, Faraggiana T, Mazzucco G, Monga G, Sacchi G (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18:240–248
Park MH, D’Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309–319
Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1–17
Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G (2010) Tubulointerstitial lesions of patients with LN classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77:820–829
Hayakawa S, Nakabayashi K, Karube M, Arimura Y, Soejima A, Yamada A, Fujioka Y (2006) Tubulointerstitial immune complex nephritis in a patient with systemic lupus erythematosus: role of peritubular capillaritis with immune complex deposits in the pathogenesis of the tubulointerstitial nephritis. Clin Exp Nephrol 10:146–151
Furness PN, Taub N (2006) Interobserver reproducibility and application of the ISN/RPS classification of lupus nephritis-a UK-wide study. Am J Surg Pathol 30:1030–1035
Schwartz MM, Korbet SM, Lewis EJ, Collaborative Study Group (2008) The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant 23:1298–1306
van der Vlag J, Berden JH (2011) Lupus nephritis: role of antinucleosome autoantibodies. Semin Nephrol 31:376–389
Bajema IM, Hagen EC, Hermans J, Noël LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751–1758
Hauer HA, Bajema IM, Hagen EC, Noël LH, Ferrario F, Waldherr R, van Houwelingen HC, Lesavre P, Sinico RA, van der Woude F, Gaskin G, Verburgh CA, de Heer E, Bruijn JA (2002) Long-term renal injury in ANCA- associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant 17:587–596
Yoo CW, Kim M-K, Lee HS (2000) Predictors of renal outcome in diffuse proliferative lupus nephropathy: data from repeat renal biopsy. Nephrol Dial Transplant 15:1604–1608
Martins L, Rocha G, Rodrigues A, Santos J, Vasconcelos C, Correia J, Farinha F, Almeida I, Barbosa P, Guimarães S (2002) Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 57:114–119
Hill GS, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, Bariéty J (2001) Predictive power of the second biopsy in lupus nephritis: significance of macrophages. Kidney Int 59:304–316
Contreras G, Pardo V, Cely C, Borja E, Hurtado A, De La Cuesta C, Iqbal K, Lenz O, Asif A, Nahar N, Leclerq B, Leon C, Schulman I, Ramirez-Seijas F, Paredes A, Cepero A, Khan T, Pachon F, Tozman E, Barreto G, Hoffman D, Almeida Suarez M, Busse JC, Esquenazi M, Esquenazi A, Garcia Mayol L, Garcia Estrada H (2005) Factors associated with poor outcomes in patients with lupus nephritis. Lupus 14:890–895
Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD (2000) Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 35:904–914
Bono L, Cameron JS, Hicks JA (1999) The very long-term prognosis and complications of lupus nephritis and its treatment. Q J Med 92:211–218
Ward MM (2000) Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982–1995. Arch Intern Med 160:3136–3140
Lightstone L (2013) Minimising steroids in lupus nephritis – will B cell depletion pave the way? Lupus 22:390–399
Hogan J, Appel GB (2013) Update on the treatment of lupus nephritis. Curr Opin Nephrol Hypertens 22:224–230
Maroz N, Segal MS (2013) Lupus nephritis and end-stage kidney disease. Am J Med Sci (in press)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fogo, A.B., Cohen, A.H., Colvin, R.B., Jennette, J.C., Alpers, C.E. (2014). Lupus Nephritis. In: Fundamentals of Renal Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39080-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-39080-7_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39079-1
Online ISBN: 978-3-642-39080-7
eBook Packages: MedicineMedicine (R0)